Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU patient groups to review package leaflets for new medicines

This article was originally published in SRA

Executive Summary

Patients’ and consumers’ organisations in the European Union will from now on be able to take part in the review of medicine package leaflets at the time of marketing authorisation, rather than just at the time of the five-year renewal, the European Medicines Agency has announced1. PCOs will continue to be involved in reviewing the summaries of European Public Assessment Reports that are routinely published by the EMEA for approved medicines.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel